title: Pro: Vasopressin is the vasoconstrictor of choice after cardiopulmonary bypass.
authors.affiliation: Division of Cardiothoracic Anesthesia and Critical Care, Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA. booth006@mc.duke.edu
authors.forename: John V
authors.initials: JV
authors.lastname: Booth
authors.forename: David
authors.initials: D
authors.lastname: Schinderle
authors.forename: Ian J
authors.initials: IJ
authors.lastname: Welsby
mesh_terms: D001794:Blood Pressure / Q000187:drug effects; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D006801:Humans; D012769:Shock / Q000209:etiology / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology; D014667:Vasopressins / Q000008:administration & dosage* / Q000494:pharmacology
chemical_list: D014662:Vasoconstrictor Agents; D014667:Vasopressins